Publications by authors named "Ulrike Glaenzel"

9Publications

Absorption, Distribution, Metabolism, and Excretion of Capmatinib (INC280) in Healthy Male Volunteers and In Vitro Aldehyde Oxidase Phenotyping of the Major Metabolite.

Drug Metab Dispos 2020 10 14;48(10):873-885. Epub 2020 Jul 14.

PK-Sciences, Novartis Pharma AG, Basel, Switzerland (U.G., Y.J., G.R., U.P., H.B., A.M., G.C., S.Z.); Preclinical Safety, Novartis Pharma AG, Basel, Switzerland (R.H.); Novartis Global Discovery Chemistry, Novartis Pharma AG, Basel, Switzerland (K.S., A.M.); and PRA Health Sciences, The Netherlands (J.J.v.L.).

View Article and Find Full Text PDF
October 2020

Metabolism and Disposition of Siponimod, a Novel Selective S1P/S1P Agonist, in Healthy Volunteers and In Vitro Identification of Human Cytochrome P450 Enzymes Involved in Its Oxidative Metabolism.

Drug Metab Dispos 2018 07 7;46(7):1001-1013. Epub 2018 May 7.

PK-Sciences, Novartis Pharma AG, Basel, Switzerland (U.G., Y.J., R.N., W.L., K.S., S.A.-S., E.L., H.B., A.D.J., A.M., G.C., A.G.), and PRA Health Sciences, Raleigh, North Carolina (S.P.M.).

View Article and Find Full Text PDF
July 2018

Absorption, Distribution, Metabolism, and Excretion of the Oral Prostaglandin D2 Receptor 2 Antagonist Fevipiprant (QAW039) in Healthy Volunteers and In Vitro.

Drug Metab Dispos 2017 07 25;45(7):817-825. Epub 2017 Apr 25.

Novartis Institutes for Biomedical Research, Novartis Pharma AG, Basel, Switzerland (D.P., H.M.W., Y.J., V.J.E., U.G., P.E., R.W., F.E., G.C.); PRA International, Early Development Services, Zuidlaren, the Netherlands (J.J.v.L.).

View Article and Find Full Text PDF
July 2017

Absorption, distribution, metabolism, and excretion of [(14)C]BYL719 (alpelisib) in healthy male volunteers.

Cancer Chemother Pharmacol 2015 Oct 8;76(4):751-60. Epub 2015 Aug 8.

Department of Drug Metabolism and Pharmacokinetics (DMPK), Novartis Institutes for BioMedical Research, Fabrikstrasse 14, 4002, Basel, Switzerland.

View Article and Find Full Text PDF
October 2015

Pharmacokinetics, metabolism, and disposition of deferasirox in beta-thalassemic patients with transfusion-dependent iron overload who are at pharmacokinetic steady state.

Drug Metab Dispos 2010 May 22;38(5):808-16. Epub 2010 Jan 22.

Novartis Institutes for BioMedical Research-Drug Metabolism and Pharmacokinetics, Novartis Campus, WSJ-210.4.20, Postfach, CH-4056 Basel, Switzerland.

View Article and Find Full Text PDF
May 2010